- Home
- UFI vs XFOR Comparison
UFI vs XFOR Comparison
Compare UFI & XFOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UFI
- XFOR
- Stock Information
- Founded
- UFI 1969
- XFOR 2014
- Country
- UFI United States
- XFOR United States
- Employees
- UFI N/A
- XFOR N/A
- Industry
- UFI Textiles
- XFOR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- UFI Consumer Discretionary
- XFOR Health Care
- Exchange
- UFI Nasdaq
- XFOR Nasdaq
- Market Cap
- UFI 86.8M
- XFOR 84.3M
- IPO Year
- UFI N/A
- XFOR N/A
- Fundamental
- Price
- UFI $4.51
- XFOR $3.26
- Analyst Decision
- UFI
- XFOR Strong Buy
- Analyst Count
- UFI 0
- XFOR 3
- Target Price
- UFI N/A
- XFOR $34.17
- AVG Volume (30 Days)
- UFI 59.1K
- XFOR 1.6M
- Earning Date
- UFI 10-29-2025
- XFOR 11-12-2025
- Dividend Yield
- UFI N/A
- XFOR N/A
- EPS Growth
- UFI N/A
- XFOR N/A
- EPS
- UFI N/A
- XFOR N/A
- Revenue
- UFI $571,344,000.00
- XFOR $32,774,000.00
- Revenue This Year
- UFI $12.46
- XFOR $1,313.84
- Revenue Next Year
- UFI $5.64
- XFOR N/A
- P/E Ratio
- UFI N/A
- XFOR N/A
- Revenue Growth
- UFI N/A
- XFOR 5721.31
- 52 Week Low
- UFI $4.25
- XFOR $1.35
- 52 Week High
- UFI $7.85
- XFOR $26.83
- Technical
- Relative Strength Index (RSI)
- UFI 51.39
- XFOR 52.11
- Support Level
- UFI $4.29
- XFOR $3.08
- Resistance Level
- UFI $4.63
- XFOR $3.79
- Average True Range (ATR)
- UFI 0.16
- XFOR 0.48
- MACD
- UFI 0.02
- XFOR -0.10
- Stochastic Oscillator
- UFI 67.89
- XFOR 13.07
About UFI Unifi Inc. New
Unifi Inc is a multi-national company. It manufactures and sells synthetic and recycled products made from polyester and nylon predominantly to other yarn manufacturers and knitters and weavers that produce fabric for apparel, hosiery, home furnishings, automotive, industrial, and other end-use markets. Polyester yarns include partially oriented yarn (POY), textured, solution and package dyed, twisted, beamed, and draw wound yarns, and each is available in virgin or recycled varieties. UNIFI offers specialized yarns, premium value-added (PVA) yarns, and commodity yarns. The company's reportable segments are; the Americas, Brazil, and Asia. Its maximum revenue is derived from the Americas.
About XFOR X4 Pharmaceuticals Inc.
X4 Pharmaceuticals Inc is a biopharmaceutical company developing and commercializing novel therapeutics for the treatment of rare diseases of the immune system. The Company's lead clinical candidate is mavorixafor, a small molecule antagonist of the chemokine receptor CXCR4 that is being developed as an oral, once-daily therapy. It can increase the mobilization of mature, functional white blood cells from the bone marrow into the bloodstream. It also has two pre-clinical candidates X4P-003 and X4P-002 which are CXCR4 antagonists with different properties.